Groundbreaking 18-Month Trial Assesses Driving Performance of Medicinal Cannabis Users in a Closed-Circuit Environment
The initial test drive has been conducted in a new closed-circuit trial aimed at assessing whether medicinal cannabis users can drive safely.
Advertisement
The trial, held at METEC Driver Training in Bayswater, marks a significant step forward in understanding how medicinal cannabis affects driving performance. Conducted by Swinburne University of Technology over 18 months with a $4.9 million funding commitment, the study focuses on the effects of THC in medicinal cannabis on critical driving skills, such as steering, braking, speed control, and managing distractions. A second trial site is planned for Anglesea to include participants from regional areas.
Throughout the trial, participants are closely monitored for their responses to various driving tasks. Strict safety protocols are in place to ensure participants and staff remain safe, with a qualified driving instructor present in every session. Dual controls allow instructors to step in immediately if necessary.
Held on a closed course designed to reflect real-world driving conditions, this trial is entirely off public roads. Participants must have been prescribed medicinal cannabis for at least six months for conditions like sleep disorders, chronic pain, or mental health issues. Each participant undergoes drug impairment screenings before and after their driving sessions to provide comprehensive data on the effects of THC on driving abilities.
